MyPL is involved in a first-of-it’s-kind international study overseen by the SIOG (International Society of Geriatric Oncology).
Over the next years, MyPL & oncological experts will be assessing in more than 16 hospital sites accross France, Belgium & The Netherlands how our numerical solutions can improve the quality of life of more than 2.000 elderly cancer patients closely monitored during the clinical trial.
MyPL has co-developed it’s solution with the active participation of leading oncologists, among whom some at the AP-HP. We are pleased to announce that an observational study has been launched on some of it’s sites and will go live in a few days, allowing us to measure in detail the performance & leverage our new v2 product brings to clinicians in their daily work.
We will regularily post on our findings & share with you results.